CD4 and neoplasm: To investigate the effects of PCC0208025 on the cellular immunity, the cell counts for CD3+, CD3+CD4+, CD3+CD8+, CD4+CD25+CD127low/− and CD8+IFN-γ+ T lymphocytes in tumor were determined by flow cytometry.